Submitted by Anonymous (not verified) on 13 October 2023 - 9:46
Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Epilepsy, Date of authorisation: 31/05/2023, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Epilepsy, Date of authorisation: 31/05/2023, Revision: 2, Status: Authorised